Senographe Pristina; SenoBright HD; Pristina Serena; Pristina Serena Bright
GE Medical Systems SCS · Decision date Mar 24, 2026
What did the FDA decide?
FDA records K260087 as a 510(k) premarket notification, with a decision dated Mar 24, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Mar 24, 2026
Regulatory record facts
- Identifier
- K260087
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- GE Medical Systems SCS
- Product code
- MUE
- Decision code
- SESE
- Decision date
- Mar 24, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Full Field Digital, System, X-Ray, Mammographic.
- Applicant
- GE Medical Systems SCS
- Product code
- MUE
- FDA device class
- 2
FDA decision timeline
K260087 received
Application receipt date recorded by FDA.
K260087 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code MUE
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
I-ViewK254090 | Hologic, Inc. | 510(k) clearance | Sep 2, 2026 | FDA |
| Siemens Medical Solutions USA, Inc. | 510(k) clearance | Jun 18, 2026 | FDA | |
Bellalun 2D (VDMS-1000S)K254092 | Vieworks Co., Ltd. | 510(k) clearance | May 28, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
GE Medical Systems SCS
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Buc
Sources and methodology
- Original FDA record: K260087
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

